Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
IPS Cell-Derived Natural Killer (iNK) Cells by ICamuno Biotherapeutics for Ovarian Cancer: Likelihood of Approval
IPS Cell-Derived Natural Killer (iNK) Cells is under clinical development by ICamuno Biotherapeutics and currently in Phase I for Ovarian...